These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33545668)

  • 21. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
    Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
    JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultra-high-risk paradigm: lessons learnt and new directions.
    McGorry PD; Mei C
    Evid Based Ment Health; 2018 Nov; 21(4):131-133. PubMed ID: 30355661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.
    Woodberry KA; Shapiro DI; Bryant C; Seidman LJ
    Harv Rev Psychiatry; 2016; 24(2):87-103. PubMed ID: 26954594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis.
    Lavoie S; Schäfer MR; Whitford TJ; Benninger F; Feucht M; Klier CM; Yuen HP; Pantelis C; McGorry PD; Amminger GP
    Schizophr Res; 2012 Jul; 138(2-3):206-11. PubMed ID: 22520856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: A systematic review.
    Albert U; Tomassi S; Maina G; Tosato S
    Psychiatry Res; 2018 Dec; 270():1-12. PubMed ID: 30243126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges of assessment and treatment of ultra high risk for psychosis in an adolescent.
    Boričević Maršanić V; Jukić J; Flander M
    Psychiatr Danub; 2018 Jun; 30(Suppl 4):166-168. PubMed ID: 29864753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis.
    Mei C; van der Gaag M; Nelson B; Smit F; Yuen HP; Berger M; Krcmar M; French P; Amminger GP; Bechdolf A; Cuijpers P; Yung AR; McGorry PD
    Clin Psychol Rev; 2021 Jun; 86():102005. PubMed ID: 33810885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social Cognition in Individuals at Ultra-High Risk for Psychosis: A Meta-Analysis.
    van Donkersgoed RJ; Wunderink L; Nieboer R; Aleman A; Pijnenborg GH
    PLoS One; 2015; 10(10):e0141075. PubMed ID: 26510175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
    Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Clinic for Assessment of Youth at Risk (CAYR): 10 years of service delivery and research targeting the prevention of psychosis in Montreal, Canada.
    Pruessner M; Faridi K; Shah J; Rabinovitch M; Iyer S; Abadi S; Pawliuk N; Joober R; Malla AK
    Early Interv Psychiatry; 2017 Apr; 11(2):177-184. PubMed ID: 26593976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sources of clinical distress in young people at ultra high risk of psychosis.
    Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
    Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.
    Ising HK; Ruhrmann S; Burger NA; Rietdijk J; Dragt S; Klaassen RM; van den Berg DP; Nieman DH; Boonstra N; Linszen DH; Wunderink L; Smit F; Veling W; van der Gaag M
    Psychol Med; 2016 Jul; 46(9):1839-51. PubMed ID: 26979398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coping strategies in individuals at ultra-high risk of psychosis: A systematic review.
    Mian L; Lattanzi GM; Tognin S
    Early Interv Psychiatry; 2018 Aug; 12(4):525-534. PubMed ID: 29761632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis and healthy controls.
    Pruessner M; Iyer SN; Faridi K; Joober R; Malla AK
    Schizophr Res; 2011 Jun; 129(1):29-35. PubMed ID: 21497058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
    Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
    Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.